Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy;Glukokortikoidinduzierte insulinresistenz und diabetes mellitus. Rezeptor-, postrezeptormechanismen, lokale cortisolwirkung und neue aspekte in der antidiabetischen therapie

Medizinische Klinik

Volumn 98, Issue 5, 2003, Pages 266-270

  Meyer, Gesine ^a   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Diabetes mellitus; Glucocorticoid induced insulin resistance; Glucocorticoids; Therapy

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR; METFORMIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; ROSIGLITAZONE;

ADIPOCYTE; ATHEROSCLEROSIS; BINDING AFFINITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DRUG CONTRAINDICATION; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; MUSCLE; PATHOPHYSIOLOGY; REVIEW;

DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; RECEPTORS, GLUCOCORTICOID;

EID: 0038287936     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-003-1255-z     Document Type: Review

References (26)

1. Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 1997;99:414-23.
2. Hollingdal M, Juhl CB, Dall R, Sturis J, Veldhuis JD, Schmitz O, Porkson N. Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. Diabetologia 2002;45:49-55.
3. De Pirro R, Bertoli A, Fusco A, Testa I, Greco AV, Lauro R. Effect of dexamethasone and cortisone on insulin receptors in normal human male. J Clin Endocrinol Metab 1980;51:503-7.
4. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Whorwood CB, Phillips DI. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001;86:245-50.
5. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalalmic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993;77:341-6.
6. Vicennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab 2000; 85:4093-8.
7. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001;86:1154-9.
8. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-34.
9. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 1999;96:513-23.
10. Andrews RC, Herlihy O, Livingstone DE, Andrew R, Walker BR. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab 2002;87: 5587-93.
11. Andrews RC, Rooyackers O, Walker BR. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 2003;88: 285-91.
12. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
13. Arlt W, Auchus RJ, Miller WL. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta-hydroxysteroid dehydrogenase. J Biol Chem 2001;276:16767-71.
14. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-inducedinsulin resistance in man: impaired suppression ofglucose production and stimulation ofglucose utilisation due to a postreceptor deficit of insulinisation. J Clin Endocrinol 1982;54:131.
15. Mehnert H, Standl E, Usadel KH. Diabetologie in Klinik und Praxis. Stuttgart: Thieme, 1999:581.
16. Reisaeter AV, Hartmann A. Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc 2001;33:Suppl 5A:8S-18S.
17. Vesco L, Busson M, Bedrossian J, Bitker MO, Hiesre C, Lary P. Diabetes mellitus after renal transplantation. Transplantation 1996;61:1475-8.
18. Marchetti P. Strategies for risk reduction and management of posttransplant diabetes mellitus. Transplant Proc 2001;33:Suppl 5A:27S-31S.
19. Weir M. Impact of immunosuppressive regimes on posttransplant diabetes mellitus. Transplant Proc 2001;33:Suppl 5A:23S-6S.
20. Markell M. Clinical impact of posttransplant diabetes mellitus. Transplant Proc 2001;33:Suppl 5A: 19S-22S.
21. Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998;13:427-31.
22. Nationale Versorgungs-Leitlinie Diabetes mellitus Typ 2. Z Arztl Fortbild Qualitätssich 2002;96:Suppl II:7-22.
23. Stratton IM, Adler AI, Neil HA, Matthews DR, Monley SE, Coll CA, Hadde O, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2001;321:405-12.
24. Rosenstock J, Schwartz SL, Clark CM, Park GO, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes. Diabetes Care 2001;24:631-6.
25. Weinstein SP, Holand A, O'Boyle E, Haber RS. Effects of thiazolindinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 1993;42:1365-9.
26. Anil Kumar KL, Marita AR. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes. Br J Phamacol 2000;130:351-8.